Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

As noted across the telehealth provider’s website and in the commercial’s fine print, compounded versions of drugs are not subject to FDA approval or evaluations of safety and quality.

Eli Lilly, the maker of Zepbound, offers a commercial savings ... broken or damaged wrapping or poor print quality — all indicators of an untrustworthy product. You should also avoid ordering ...

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

Zepbound, chemically known as tirzepatide, is the newest weight loss medication approved by the FDA. Originally approved for Type 2 diabetes under the brand name Mounjaro, Zepbound has generated a ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

Zepbound is the name of the first drug approved by the FDA for obstructive sleep apnea. According to the Mayo Clinic, obstructive sleep apnea is a common sleep-related breathing disorder that ...

Zepbound is a subcutaneous injection that needs proper storage and handling during travel. There are ways you can travel with Zepbound to ensure it remains safe and effective to use. Zepbound ...